Dr. Neville Sanjana talks about CRISPR on CUNY TV
The director of NYGC’s Center for Genomics of Neurodegenerative Disease discusses her collaborative ALS work at the NYGC.
The director of NYGC’s Center for Genomics of Neurodegenerative Disease discusses her collaborative ALS work at the NYGC.
A study published today in Science, in which researchers used thousands of CRISPRs — new gene editing tools that have been applied to everything from plants to humans — to mutate noncoding regions of the human genome may offer new treatment options to patients with advanced melanoma and other cancers. Often referred to in the popular […]